Briacell Therapeutics (BCTX) Free Cash Flow by Year
Briacell Therapeutics Corp. recorded an outflow of $28.8M in free cash flow in fiscal year 2026. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters Briacell Therapeutics Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BCTX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BCTX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Briacell Therapeutics Corp. financials
Frequently Asked Questions
Briacell Therapeutics Corp. recorded an outflow of $28.8M in free cash flow in fiscal year 2026.
Briacell Therapeutics Corp. (BCTX) reported -$6.0M in free cash flow in Q4 2026.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Briacell Therapeutics Corp. (BCTX) reported on that line in every period on record.